Last update Sept. 2, 2021
Very Low Risk
Second-generation cephalosporin for oral or parenteral administration in two daily doses.
Like most cephalosporins for which data are available, excretion occurs in breast milk in very small amount and it is clinically insignificant (Kiriazopoulos 2017, Nakamura 1987, Amiraslanova 1985, Voropaeva 1982).
No problems have been observed in infants whose mothers have taken it (Benyamini 2005).
Intravenously administered Cefuroxime salt is not orally absorbed.
Cephalosporins are widely used in the Pediatric practice with a good tolerance (Powell 1991), even in the neonatal period, so it is very unlikely that in small amounts through milk would be a cause of problems in the infant.
Although rare, the possibility of transient gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibiotics should be taken into account (Benyamini 2005, Ito 1993).
Expert authors consider the use of this medication safe during breastfeeding (Hale, Lactmed, Briggs 2015, Schaefer 2015, Rowe 2013).
We do not have alternatives for J01DC02; S01AA27 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM